Bio-Connect
WB analysis of 293T cell lysates using GTX11843 E2F3 antibody [PG30]. Dilution : Lane1 : 4 microg/mL Lane2 : 8 microg/mL
WB analysis of 293T cell lysates using GTX11843 E2F3 antibody [PG30]. Dilution : Lane1 : 4 microg/mL Lane2 : 8 microg/mL
WB analysis of 293T cell lysates using GTX11843 E2F3 antibody [PG30]. Dilution : Lane1 : 4 microg/mL Lane2 : 8 microg/mL

E2F3 antibody [PG30]

GTX11843
GeneTex
ApplicationsImmunoPrecipitation, Western Blot
Product group Antibodies
ReactivityHuman
TargetE2F3
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    GeneTex
  • Product Name
    E2F3 antibody [PG30]
  • Delivery Days Customer
    9
  • Application Supplier Note
    WB: 4-8 microg/ml. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
  • Applications
    ImmunoPrecipitation, Western Blot
  • Certification
    Research Use Only
  • Clonality
    Monoclonal
  • Clone ID
    PG30
  • Concentration
    2 mg/ml
  • Conjugate
    Unconjugated
  • Gene ID1871
  • Target name
    E2F3
  • Target description
    E2F transcription factor 3
  • Target synonyms
    E2F-3, transcription factor E2F3
  • Host
    Mouse
  • Isotype
    IgG2a
  • Protein IDO00716
  • Protein Name
    Transcription factor E2F3
  • Scientific Description
    E2F transcription factors are functionally regulated by binding to Rb p110, p107, and p130. E2F 3 is regulated by complex formation with Rb p110. E2F family members bind DNA as heterodimers with members of the DP family of polypeptides.
  • Reactivity
    Human
  • Storage Instruction
    -20°C or -80°C,2°C to 8°C
  • UNSPSC
    12352203

References

  • Simoneschi D, Rona G, Zhou N, et al. CRL4(AMBRA1) is a master regulator of D-type cyclins. Nature. 2021,592(7856):789-793. doi: 10.1038/s41586-021-03445-y
    Read this paper
  • Giro-Perafita A, Luo L, Khodadadi-Jamayran A, et al. LncRNA RP11-19E11 is an E2F1 target required for proliferation and survival of basal breast cancer. NPJ Breast Cancer. 2020,6:1. doi: 10.1038/s41523-019-0144-4
    Read this paper
  • Clijsters L, Hoencamp C, Calis JJA, et al. Cyclin F Controls Cell-Cycle Transcriptional Outputs by Directing the Degradation of the Three Activator E2Fs. Mol Cell. 2019,74(6):1264-1277.e7. doi: 10.1016/j.molcel.2019.04.010
    Read this paper